Upsized and target-topping Bay Area biotech IPO scores $252M
July 10, 2020 at 10:17 AM EDT
The South San Francisco company is the seventh life sciences IPO from the region in a year when there has yet to be a Wall Street debut by a native Bay Area tech company.